期刊名称：PARKINSONS DISEASE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Parkinson’s Disease is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of Parkinson’s disease.
Parkinson's Disease has been recently accepted for indexing in the Science Citation Index Expanded and will receive its first Impact Factor in mid 2014.
Abstracting and Indexing
The articles of Parkinson's Disease are included in the following databases/resources:
- Academic OneFile
- Academic Search Alumni Edition
- Academic Search Complete
- Airiti Library
- Chemical Abstracts Service (CAS)
- CINAHL Plus with Full Text
- CNKI Scholar
- Community Health
- Directory of Open Access Journals (DOAJ)
- EBSCO Academic Source Complete
- EBSCO Discovery Service
- EBSCOhost Connection
- EMBASE
- Expanded Academic ASAP
- Google Scholar
- Health and Wellness Resource Center
- Health Reference Center Academic
- HINARI Access to Research in Health Programme
- J-Gate Portal
- Journal Citation Reports: Science Edition
- PubMed
- PubMed Central
- Science Citation Index Expanded
- Scopus
Aims and Scope
Parkinson’s Disease is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of Parkinson’s disease
Instructions to Authors
Submission
Manuscripts should be submitted by one of the authors of the manuscript through the online Manuscript Tracking System. Regardless of the source of the word-processing tool, only electronic PDF (.pdf) or Word (.doc, .docx, .rtf) files can be submitted through the MTS. There is no page limit. Only online submissions are accepted to facilitate rapid publication and minimize administrative costs. Submissions by anyone other than one of the authors will not be accepted. The submitting author takes responsibility for the paper during submission and peer review. If for some technical reason submission through the MTS is not possible, the author can contact pd@hindawi.com for support.
Terms of Submission
Papers must be submitted on the understanding that they have not been published elsewhere and are not currently under consideration by another journal published by Hindawi or any other publisher. The submitting author is responsible for ensuring that the article's publication has been approved by all the other coauthors. It is also the authors' responsibility to ensure that the articles emanating from a particular institution are submitted with the approval of the necessary institution. Only an acknowledgment from the editorial office officially establishes the date of receipt. Further correspondence and proofs will be sent to the author(s) before publication unless otherwise indicated. It is a condition of submission of a paper that the authors permit editing of the paper for readability. All enquiries concerning the publication of accepted papers should be addressed to pd@hindawi.com.
Peer Review
All manuscripts are subject to peer review and are expected to meet standards of academic excellence. Submissions will be considered by an editor and “if not rejected right away” by peer-reviewers, whose identities will remain anonymous to the authors.
Article Processing Charges
Parkinson's Disease is an open access journal. Open access charges allow publishers to make the published material available for free to all interested online visitors. For more details about the article processing charges of Parkinson's Disease, please visit the Article Processing Charges information page.
Units of Measurement
Units of measurement should be presented simply and concisely using System International (SI) units.
Title and Authorship Information
The following information should be included
- Paper title
- Full author names
- Full institutional mailing addresses
- Email addresses
Abstract
The manuscript should contain an abstract. The abstract should be self-contained and citation-free and should not exceed 200 words.
Introduction
This section should be succinct, with no subheadings.
Materials and Methods
This part should contain sufficient detail so that all procedures can be repeated. It can be divided into subsections if several methods are described.
Results and Discussion
This section may each be divided by subheadings or may be combined.
Conclusions
This should clearly explain the main conclusions of the work highlighting its importance and relevance.
Acknowledgments
All acknowledgments (if any) should be included at the very end of the paper before the references and may include supporting grants, presentations, and so forth.
References
Authors are responsible for ensuring that the information in each reference is complete and accurate. All references must be numbered consecutively and citations of references in text should be identified using numbers in square brackets (e.g., “as discussed by Smith [9]”; “as discussed elsewhere [9, 10]”). All references should be cited within the text; otherwise, these references will be automatically removed.
Preparation of Figures
Upon submission of an article, authors are supposed to include all figures and tables in the PDF file of the manuscript. Figures and tables should not be submitted in separate files. If the article is accepted, authors will be asked to provide the source files of the figures. Each figure should be supplied in a separate electronic file. All figures should be cited in the paper in a consecutive order. Figures should be supplied in either vector art formats (Illustrator, EPS, WMF, FreeHand, CorelDraw, PowerPoint, Excel, etc.) or bitmap formats (Photoshop, TIFF, GIF, JPEG, etc.). Bitmap images should be of 300 dpi resolution at least unless the resolution is intentionally set to a lower level for scientific reasons. If a bitmap image has labels, the image and labels should be embedded in separate layers.
Preparation of Tables
Tables should be cited consecutively in the text. Every table must have a descriptive title and if numerical measurements are given, the units should be included in the column heading. Vertical rules should not be used.
Proofs
Corrected proofs must be returned to the publisher within 2-3 days of receipt. The publisher will do everything possible to ensure prompt publication. It will therefore be appreciated if the manuscripts and figures conform from the outset to the style of the journal.
Copyright
Open Access authors retain the copyrights of their papers, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
Disclosure Policy
A competing interest exists when professional judgment concerning the validity of research is influenced by a secondary interest, such as financial gain. We require that our authors reveal any possible conflict of interests in their submitted manuscripts.
If there is no conflict of interests, authors should state that “The author(s) declare(s) that there is no conflict of interests regarding the publication of this article.”
Clinical Study
When publishing clinical studies, Hindawi aims to comply with the recommendations of the International Committee of Medical Journal Editors (ICMJE) on trials registration. Therefore, authors are requested to register the clinical trial presented in the manuscript in a public trials registry and include the trial registration number at the end of the abstract. Trials initiated after July 1, 2005 must be registered prospectively before patient recruitment has begun. For trials initiated before July 1, 2005, the trial must be registered before submission.
Ethical Guidelines
In any studies that involve experiments on human or animal subjects, the following ethical guidelines must be observed. For any human experiments, all work must be conducted in accordance with the Declaration of Helsinki (1964). Papers describing experimental work on human subjects who carry a risk of harm must include a statement that the experiment was conducted with the understanding and the consent of the human subject, as well as a statement that the responsible Ethical Committee has approved the experiments. In the case of any animal experiments, the authors should provide a full description of any anesthetic and surgical procedure used, as well as evidence that all possible steps were taken to avoid animal suffering at each stage of the experiment.
Editorial Board
Contact Information
Email Addresses
Editorial Office: pd@hindawi.com
Postal Addresses
Hindawi Publishing Corporation
410 Park Avenue
15th Floor, #287 pmb
New York, NY 10022
USA
Hindawi Publishing Corporation
Cairo Free Zone
Road 5, Block E
Nasr City, Cairo 11816
Egypt
Editorial Board
- Jan O. Aasly, Norwegian University of Science and Technology, Norway
- Cristine Alves da Costa, Centre National de la Research Scientifique, France
- Ivan Bodis-Wollner, SUNY Downstate Medical Center, USA
- Carlo Colosimo, Università degli studi di Roma La Sapienza, Italy
- Alan R. Crossman, University of Manchester, United Kingdom
- Ted Dawson, Johns Hopkins University, USA
- Howard J. Federoff, Georgetown University, USA
- Francisco Grandas, Hospital Universitario Gregorio Marañón, Spain
- Peter Hagell, Kristianstad University, Sweden
- Nobutaka Hattori, Juntendo University, Japan
- Marjan Jahanshahi, UCL Institute of Neurology, United Kingdom
- E. D. Louis, Columbia University, USA
- P. Martinez Martin, Instituto de Salud Carlos III, Spain
- Huw R. Morris, UCL Institute of Neurology, United Kingdom
- M. Maral Mouradian, University of Medicine and Dentistry of New Jersey, USA
- Antonio Pisani, University of Rome Tor Vergata, Italy
- Jose Rabey, Assaf Harofeh Medical Center, Israel
- Heinz Reichmann, Uniklinikum Dresden, Germany
- Fabrizio Stocchi, San Raffaele Scientific Institute, Italy
- Eng-King Tan, National Neuroscience Institute, Singapore
- Hélio Teive, Federal University of Paraná, Brazil
- Daniel Truong, The Parkinson's and Movement Disorder Institute, USA
- Yoshikazu Ugawa, Fukushima Medical University, Japan
|
